Epidemiology, Pathogenesis, and Vaccine Development of Acne

Authors

  • Shuyu Zong

DOI:

https://doi.org/10.61173/7k6v1c78

Keywords:

Acne, acne inflammation, acne pathogenesis, cutibacterium acnes, vaccine

Abstract

Acne is a widespread and chronic inflammatory disease of the pilosebaceous glands affecting millions of people worldwide, particularly among adolescents. The current treatment method is mainly oral and smear medication, combined with a variety of physical and chemical therapy used as adjuvant therapy, alternative therapy or sequelae treatment. However, due to antibiotic resistance and bacteria evolve over time, need a vaccine as a new alternative treatment, in recent years, with the rapid development of molecular biology and immunology, based on specific antigen antibody technology acne vaccine has made significant progress, but there is still no successful development of acne vaccine. This paper analyzes the main four pathogenesis of acne and the current treatment, including oral and daub anti-inflammatory drugs and antibacterial drugs, supplemented by physical and chemical therapy, focus on the development of acne vaccine, present situation, challenges and future trend, hope to further promote the research and development of acne vaccine provide certain theoretical basis and reference value, and provide new ideas and methods for the prevention and treatment of acne. And acne pathogenesis complex and cannot determine the vaccine clinical trial effect these two problems are not solved, pathogenic mechanism involves multiple complex factors, a single vaccine may not have enough protective effect, difficult to completely prevent or cure acne, therefore, the next step need to consider targeting multiple pathogens and virulence factors combination of multivalent vaccine, and need for long-term clinical trials and observation.

References

[1] Zouboulis CC, Eady A, Philpott M, et al. What is the pathogenesis of acne? Exp Dermatol, 2005, 14(2): 143-152.

[2] Tan AU, Schlosser BJ, Paller AS. A review of diagnosis and treatment of acne in adult female patients. Int J Womens Dermatol, 2017, 4(2): 56-71.

[3] Mohsin N, Hernandez LE, Martin MR, et al. Acne treatment review and future perspectives. Dermatologic Therapy, 2022, 35(9): e15719.

[4] Vasam M, Korutla S, Bohara RA. Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances. Biochem Biophys Rep, 2023, 36: 101578.

[5] Li Donglin, Wu Wenjuan, Zou Dandan, HE Li. Research Progress in Acne Vulgaris. Journal of Kunming Medical University, 2018, 39(10): 1-6.

[6] Kim HJ, Kim YH. Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies. Int J Mol Sci, 2024, 25(10): 5302.

[7] Yu Y, Champer J, Agak GW, et al. Different Propionibacterium acnes Phylotypes Induce Distinct Immune Responses and Express Unique Surface and Secreted Proteomes. J Invest Dermatol, 2016, 136(11): 2221-2228.

[8] Beylot C, Auffret N, Poli F, et al. Propionibacterium acnes: an update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol, 2014, 28(3): 271-278.

[9] Kuehnast T, Cakar F, Weinhäupl T, et al. Comparative analyses of biofilm formation among different Cutibacterium acnes isolates. Int J Med Microbiol, 2018, 308(8): 1027-1035.

[10] Barnard E, Shi B, Kang D, et al. The balance of metagenomic elements shapes the skin microbiome in acne and health. Sci Rep, 2016, 6: 39491.

[11] Cobian N, Garlet A, Hidalgo-Cantabrana C, et al. Comparative Genomic Analyses and CRISPR-Cas Characterization of Cutibacterium acnes Provide Insights Into Genetic Diversity and Typing Applications. Front Microbiol, 2021, 12: 758749.

[12] Fitz-Gibbon S, Tomida S, Chiu BH, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol, 2013, 133(9): 2152- 2160.

[13] Mitchell BL, Saklatvala JR, Dand N, et al. Genome-wide association meta-analysis identifies 29 new acne susceptibility loci. Nat Commun, 2022, 13(1): 702.

[14] Topical Products Used for the Treatment of Common Skin Infections. https://www.healio.com/news/pediatrics/20120325/ topical-products-used-for-the-treatment-of-common-skininfections.

[15] Jaiswal S, Jawade S, Madke B, Gupta S. Recent Trends in the Management of Acne Vulgaris: A Review Focusing on Clinical Studies in the Last Decade. Cureus, 2024, 16(3): e56596.

[16] Nicholas Brownstone. Novel Triple-Combination Acne Treatment Shows Early, Significant Results. Dermatol Times, 2022, 43(6): 35.

[17] Habeshian KA, Cohen BA. Current Issues in the Treatment of Acne Vulgaris. Pediatrics, 2020, 145(Suppl 2): S225-S230.

[18] Fox L, Csongradi C, Aucamp M, et al. Treatment Modalities for Acne. Molecules, 2016, 21(8): 1063.

[19] Greydanus DE, Azmeh R, Cabral MD, et al. Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life. Dis Mon, 2021, 67(4): 101103.

[20] Goldman L, Michael JG, Riebel S. The immunobiology of acne. A polyvalent proprionibacteria vaccine. Cutis, 1979, 23(2): 181-184.

[21] Nakatsuji T, Liu YT, Huang CP, et al. Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris. J Invest Dermatol, 2008, 128(10): 2451-2457.

[22] Taylor G. Sialidases: structures, biological significance and therapeutic potential. Curr Opin Struct Biol, 1996, 6(6): 830- Dean&Francis 837.

[23] Keshari S, Kumar M, Balasubramaniam A, et al. Prospects of acne vaccines targeting secreted virulence factors of Cutibacterium acnes. Expert Rev Vaccines, 2019, 18(5): 433- 437.

[24] Wang Y, Xiao S, Ren J, Zhang Y. Analysis of the epidemiological burden of acne vulgaris in China based on the data of global burden of disease 2019. Front Med (Lausanne), 2022, 9: 939584.

[25] Hajam IA, Katiki M, McNally R, et al. Functional divergence of a bacterial enzyme promotes healthy or acneic skin. Nat Commun, 2023, 14(1): 8061.

[26] Zhang Rui, Lü Meiyu, Zhang Jianjun, et al. Research Progress on Establishing and Evaluation of Acne Animal Models. Laboratory Animals and Comparative Medicine, 2023, 43(4): 398-405.

Downloads

Published

2024-10-29